Laura Ridolfi

9PUBLICATIONS
58CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Neurosciences not elsewhere classifiedPredictive and prognostic markersMolecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Aug 04, 2026
Circulating thymidine kinase activity predicts survival and optimal treatment sequencing in BRAF-mutated metastatic melanoma in the SECOMBIT trial.

|Mar 27, 2026
From a Polymorphous Low-Grade Neuroepithelial Tumor to a Glioblastoma in an Adult Patient with FGFR3-TACC3 Fusion: A Case Report and Literature Review of the Molecular Profile.

Lorena Gurrieri, Nada Riva, Alessia Tomassini

|Sep 27, 2025
Enhancing Timeliness and Compliance of Osteoporosis Care in Oncology: Evidence from a Dedicated Bone Health Service.

William Balzi, Valentina Danesi, Andrea Roncadori

|Jul 02, 2024
In vitro CAR-T cell killing: validation of the potency assay.

Claudia Piccinini, Silvia Carloni, Chiara Arienti

|Nov 14, 2023
Immunocheckpoint Inhibitors in Microsatellite-Stable or Proficient Mismatch Repair Metastatic Colorectal Cancer: Are We Entering a New Era?

Laura Matteucci, Alessandro Bittoni, Graziana Gallo

|Mar 30, 2023
The Renewal of Cancer Immunotherapy.

Jenny Bulgarelli, Sara Pignatta, Massimiliano Petrini

Pageof 2

Frequent Collaborators

3 joint publications

Massimiliano Petrini

3 joint publications

Jenny Bulgarelli

2 joint publications

Marco Tucci

2 joint publications

Vanna Chiaron Sileni